Skip to content

Clinical trials

Immune System Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Country / region: United States Clear all

218 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20011
20021
20055
20062
20073
20082
20094
20109
20116
20129
20135
20143
20156
201613
201710
201811
20199
202012
202117
202214
202320
20247
202510
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed100
Recruiting44
Terminated31
Active, not recruiting26
Unknown status7
Enrolling by invitation4
No longer available3
Withdrawn2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)10
UNC Lineberger Comprehensive Cancer Center8
National Center for Research Resources (NCRR)7
Kadmon, a Sanofi Company5
National Cancer Institute (NCI)5
Pfizer5
AstraZeneca4
Eli Lilly and Company4
Ellodi Pharmaceuticals, LP4
Inmagene LLC4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases218
Autoimmune Diseases65
Immunoproliferative Disorders32
Lymphoproliferative Disorders32
Neoplasms31
Hematologic Diseases29
Lupus Erythematosus, Systemic25
Connective Tissue Diseases24
Lymphoma24
Hypersensitivity23

Trials

Showing 1 to 25 of 218. Each trial links to its page on Pharma Observatory.

118 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.